CPT code 90585 denotes a live vaccine product administered through the skin to protect against tuberculosis. This code identifies intradermal delivery of a live attenuated mycobacterial vaccine used in preventive public health and clinical immunization programs. Nationally, accurate coding for TB vaccination supports surveillance, public health reporting, and appropriate claims adjudication for preventive services.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will gain a concise understanding of the clinical context for CPT code 90585, the typical service setting, and which major payers are relevant for coverage and claims processing. The publication summarizes common billing modifiers (provided), typical sites of service, and practical coding considerations for vaccine administration claims.

The report covers benchmarks and policy context relevant to national payers, outlines areas where code-specific guidance commonly matters (vaccine product identification, administration route, and site of service), and highlights where additional payer-specific rules or prior authorization requirements may appear. Data not available in the input (such as associated taxonomies, ICD-10 diagnoses, and related codes) are noted as missing.